[HTML][HTML] B cell depletion therapies in autoimmune disease: advances and mechanistic insights
DSW Lee, OL Rojas, JL Gommerman - Nature reviews Drug discovery, 2021 - nature.com
In the past 15 years, B cells have been rediscovered to be not merely bystanders but rather
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
B cell depletion therapies in autoimmune disease: advances and mechanistic insights.
DSW Lee, OL Rojas, JL Gommerman - Nature Reviews Drug …, 2021 - go.gale.com
In the past 15 years, B cells have been rediscovered to be not merely bystanders but rather
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
B cell depletion therapies in autoimmune disease: advances and mechanistic insights.
DSW Lee, OL Rojas, JL Gommerman - Nature reviews. Drug …, 2020 - europepmc.org
In the past 15 years, B cells have been rediscovered to be not merely bystanders but rather
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
[HTML][HTML] B cell depletion therapies in autoimmune disease: advances and mechanistic insights
DSW Lee, OL Rojas, JL Gommerman - Nature Reviews. Drug …, 2021 - ncbi.nlm.nih.gov
In the past 15 years, B cells have been rediscovered to be not merely bystanders but rather
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
DSW Lee, OL Rojas… - Nature reviews. Drug …, 2021 - pubmed.ncbi.nlm.nih.gov
In the past 15 years, B cells have been rediscovered to be not merely bystanders but rather
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
[引用][C] B cell depletion therapies in autoimmune disease: advances and mechanistic insights
DSW Lee, OL Rojas, JL Gommerman - Nature Reviews Drug Discovery, 2020 - cir.nii.ac.jp
B cell depletion therapies in autoimmune disease: advances and mechanistic insights | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
B cell depletion therapies in autoimmune disease: advances and mechanistic insights.
DSW Lee, OL Rojas, JL Gommerman - Nature reviews. Drug …, 2020 - europepmc.org
In the past 15 years, B cells have been rediscovered to be not merely bystanders but rather
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …